Back to Report Store Home

Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma

  • Published: Jul-2010
  • Report Code: GBIHC039MR
  • Report Format: pdf

Description

GBI Research’s report, “Epigenetics - Novel Approaches in Prognosis, Diagnosis and Treatment of Chronic Diseases”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the technology that shape the industry dynamics for the key geographies: the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and analyzes the licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

  • The scope of this report includes:

  • Annualized market data from 2001 to 2009, forecast forward to 2016.

  • Analysis of the leading technology in this space

  • Analysis of the leading technology in this space

  • Market characterization

  • Key drivers and barriers that have a significant impact on the market.

  • Competitive benchmarking of leading companies.

Reasons To Buy

  • The report will enhance your decision making capability. It will allow you to

  • Align your product portfolio to the markets with high growth potential.

  • Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.

  • Reinforce R&D pipelines

  • Develop key strategic initiatives by understanding the key focus areas of leading companies.

  • Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards